Skip to main content
. 2020 Oct 26;23(5):498–508. doi: 10.4048/jbc.2020.23.e58

Figure 1. Association between late recurrence-free survival outcome by recurrence site and serum 25(OH)D status after 5-year adjuvant endocrine therapy: (A) all sites, (B) local recurrence, (C) regional lymph node recurrence, (D) bone recurrence, and (E) visceral recurrence.

Figure 1

25(OH)D = 25-hydroxyvitamin D.